Kinetics and seroprevalence of SARS-CoV-2 antibodies: a comparison of 3 different assays

Código QR

Kinetics and seroprevalence of SARS-CoV-2 antibodies: a comparison of 3 different assays

Abstract Comparing seroprevalence and antibody kinetics in three different commercially available assays for SARS-CoV-2. Serostatus of COVID-19 patients was analyzed 5 months and 10 months after their infection, using three different assays: Diasorin LIAISON, Euroimmun, Abbott Diagnostics ARCHITECT....

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Elisabeth Kahre, Lukas Galow, Manja Unrath, Luise Haag, Judith Blankenburg, Alexander H. Dalpke, Christian Lück, Reinhard Berner, Jakob P. Armann
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/3ad06cb755d9481f99002db848a9c614
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Novel Assay to Measure Seroprevalence of Zika Virus in the Philippines
por: Cameron Adams, et al.
Publicado: (2021)

Antibody Responses to SARS-CoV-2 Infection—Comparative Determination of Seroprevalence in Two High-Throughput Assays versus a Sensitive Spike Protein ELISA
por: Dinesh Mohanraj, et al.
Publicado: (2021)

Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assays
por: Christos Fotis, et al.
Publicado: (2021)

SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in Cameroon
por: Kene Nwosu, et al.
Publicado: (2021)

Estimated seroprevalence of SARS-CoV-2 antibodies among adults in Orange County, California
por: Tim A. Bruckner, et al.
Publicado: (2021)

Seroprevalence of Antibodies to SARS-CoV-2 in Guangdong Province, China between March to June 2020
por: Cheng Xiao, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study
por: Anton Barchuk, et al.
Publicado: (2021)

Diagnostic value of islet autoantibody assays practised in Russia. 1. Classic immunofluorescence islet cell antibody assay, immunoradiometric glutamic acid decarboxylase antibody assay, and ELISA tyrosine phosphatase antibody and insulin antibody assays
por: Alexei V. Timofeev, et al.
Publicado: (2016)

Seroprevalence Of IgG Antibodies Against Borrelia burgdorferi In Dogs In Belgrade Area, Serbia
por: Sonja OBRENOVIĆ, et al.
Publicado: (2015)

Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany
por: N. Ahmad Aziz, et al.
Publicado: (2021)

Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola
por: Cruz S. Sebastião, et al.
Publicado: (2021)

Infection induced SARS-CoV-2 seroprevalence and heterogeneity of antibody responses in a general population cohort study in Catalonia Spain
por: Marianna Karachaliou, et al.
Publicado: (2021)

Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital
por: Alberto L. Garcia-Basteiro, et al.
Publicado: (2020)

Seroprevalence of antibodies to SARS-CoV-2 and predictors of seropositivity among employees of a teaching hospital in New Delhi, India
por: Pragya Sharma, et al.
Publicado: (2021)

Low SARS-CoV-2 seroprevalence in the Austrian capital after an early governmental lockdown
por: Marie-Kathrin Breyer, et al.
Publicado: (2021)

Seroprevalence of antibodies against Borrelia burgdorferi sensu lato in healthy blood donors in Romania: an update
por: Zsuzsa Kalmár, et al.
Publicado: (2021)

SEROPREVALANCE OF CHLAMYDIA TRACHOMATIS ANTIBODIES IN FEMALES OF REPRODUCTIVE AGE VISITING HOLY FAMILY HOSPITAL, RAWALPINDI
por: Saima Ali Khan, et al.
Publicado: (2019)

Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses
por: Natalia Ortega, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 antibodies in the general population of Oman: results from four successive nationwide sero-epidemiological surveys
por: Seif Salem Al-Abri, et al.
Publicado: (2021)

Seroprevalence of Toxoplasma gondii IgG antibody in HIV-infected patients at the Lagos University Teaching Hospital
por: Osunkalu VO, et al.
Publicado: (2011)

Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts
por: Yachana Kataria, et al.
Publicado: (2021)

Seroprevalence of Antibodies against Tick-Borne Pathogens in Czech Patients with Suspected Post-Treatment Lyme Disease Syndrome
por: Kristyna Sloupenska, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2-specific IgG antibodies in Kashmir, India, 7 months after the first reported local COVID-19 case: results of a population-based seroprevalence survey from October to November 2020
por: Mariya Amin Qurieshi, et al.
Publicado: (2021)

Determining seropositivity-A review of approaches to define population seroprevalence when using multiplex bead assays to assess burden of tropical diseases.
por: YuYen Chan, et al.
Publicado: (2021)

A rebinding-assay for measuring extreme kinetics using label-free biosensors
por: John G. Quinn
Publicado: (2021)

Seroprevalences of specific antibodies against avian pathogens in free-ranging ring-necked pheasants (Phasianus colchicus) in Northwestern Germany.
por: Friederike Gethöffer, et al.
Publicado: (2021)

A seroprevalence study of Covid 19 antibody after 1st wave of the pandemic in South Andaman district, India
por: Deepak Kumar, et al.
Publicado: (2021)

Viral Rebound Kinetics Correlate with Distinct HIV Antibody Features
por: Yannic C. Bartsch, et al.
Publicado: (2021)

A rapid simple point-of-care assay for the detection of SARS-CoV-2 neutralizing antibodies
por: Patthara Kongsuphol, et al.
Publicado: (2021)

High-throughput quantitation of SARS-CoV-2 antibodies in a single-dilution homogeneous assay
por: Markus H. Kainulainen, et al.
Publicado: (2021)

Clinical Evaluation of Siemens SARS-CoV-2 Total Antibody assay and IgG assay using the Dimension EXL 200 in the Tokyo Metropolitan area
por: Gene Igawa, et al.
Publicado: (2021)

Seroprevalence of Severe Acute Respiratory Syndrome-Coronavirus-2 Immunoglobulin M and Immunoglobulin G Antibodies among the Population of Koya University
por: Safia S. I. Blbas, et al.
Publicado: (2021)

Standardised neutralising antibody assays are needed for evaluating COVID-19 vaccines
por: Youchun Wang
Publicado: (2021)

Seroprevalence of Cat Leptospirosis in Belgrade (Serbia)
por: Sonja Obrenović, et al.
Publicado: (2014)

A homogeneous split-luciferase assay for rapid and sensitive detection of anti-SARS CoV-2 antibodies
por: Zhong Yao, et al.
Publicado: (2021)

SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden
por: Ann-Sofie Rudberg, et al.
Publicado: (2020)

SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood
por: Dianna L. Ng, et al.
Publicado: (2020)

High seroprevalence of SARS-CoV-2 in elderly care employees in Sweden
por: Johanna F. Lindahl, et al.
Publicado: (2020)

Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo.
por: Anna Bratcher, et al.
Publicado: (2021)

Feasibility studies for assaying alpha-fetoprotein using antibody-activated magnetic nanoparticles
por: Huang KW, et al.
Publicado: (2012)